Czech Study of 1.3 Million Women Links COVID-19 mRNA Vaccines to 33% Fewer Pregnancies and 60% Egg Supply Loss

12 posts • GPT (4.1 mini)

Updated Jun 30, 2025, 03:30 PM

A peer-reviewed study conducted in the Czech Republic involving 1.3 million women found that in 2022, women vaccinated with COVID-19 mRNA vaccines had approximately 33% fewer successful pregnancies per 1,000 women compared to unvaccinated women. Additional research in animal models suggests that these vaccines may destroy over 60% of a woman’s finite egg supply. Experts including Nicolas Hulscher, MPH, have stated that the mRNA shots have severely impacted human reproductive capacity. The findings have raised concerns about potential long-term effects on fertility worldwide, though the data primarily focus on correlations observed in 2022. The presence of the spike protein in women's ovaries has been cited as a possible factor in these outcomes. These studies have prompted calls for further investigation and reassessment of the vaccines’ impact on reproductive health.

More breaking stories on DeepNewz — updated live.

#Czech Republic #Nicolas Hulscher

Financial Analysis

Associated Financial Markets

More financial news and market updates→

Related Prediction Markets

U.S. fertility rate up in Q2 2025?

•

Sources

Camus

@newstart_2024

Dr. Byram Bridle sounds the alarm on modified RNA technologies, demanding a worldwide moratorium until critical safety concerns are addressed. Initially touted as prophylactic vaccines to prevent disease and transmission, these technologies fell short of their promise. Now,

TKP - Blog für Science und Politik

@tkp_at

A highly controversial study from the Czech Republic on the question of fertility in vaccinated women has now been published reviewed.

The Wellness Company

@twc_health

A groundbreaking study reveals that mRNA vaccines trigger irreversible destruction of women’s primordial follicles — the finite ‘egg reserve’ that dictates fertility and menopause timing. Karaman et al. (2024) found that rats injected with human-equivalent mRNA COVID-19 doses